DS-1594a·HCl and DS-1594a·succinate resulted in complete remission (CR) in in vivo xenograft models of MLL1-r AML/ALL and NPM1c AML, suggesting that strong antitumor medicinal effects can be expected in clinical studies. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.